Key Insights

Highlights

Treatment Research

1 treatments under study, led by Access To Unlicensed Cord Blood Units

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01479582Phase 2Withdrawn

Providing Access to Cord Blood Units for Transplants

Showing all 1 trials

Research Network

Common Treatments

  • Access To Unlicensed Cord Blood Units1

Active Sponsors

  • National Cancer Institute (NCI)1

Top Investigators

Related Conditions

  • Nonhodgkin Lymphoma1
  • Multiple Myeloma1
  • Chronic Myelogous Leukemiaother Leukemia1
  • Acute Leukemias1

Activity Timeline